Lots of economic data on tap for next week.

Lots of economic data on tap for next week.

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

Weaker-than-expected results from Dell (DELL) pushed the tech sector lower Friday, which in turn sent the broad market skidding into the red. Disappointing results from builder D.R. Horton (DHI) also weighed on sentiment, adding to worries the real estate market will continue to hamper a recovery in the U.S. economy.[More...]

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5127282 for the full story.

Company Applauds Leadership of Sens. Dianne Feinstein and Barbara Boxer, Governor Arnold Schwarzenegger, Representative Anna Eshoo

Company Applauds Leadership of Senators Amy Klobuchar and Al Franken, Governor Tim Pawlenty and the Minnesota Congressional Delegation

Company Applauds Leadership of Senator Evan Bayh and the Indiana Delegation

Medtronic (NYSE: MDT) closed yesterday at $39.71. So far the stock has hit a 52-week low of $24.06 and 52-week high of $40.22. Medtronic stock has been showing support around 39.17 and resistance in the 40.37 range. Technical indicators for the stock are Bullish and S&P gives MDT a positive 4 STAR (out of ...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)

Global Partnership with Vital Images Leverages Advanced Visualization Technology to Streamline Pre-Case Planning through Patient Follow-Up

Medtronic Inc. (MDT) recently launched a new TSRH 3Dx Spinal System, which is a hook, rod and screw system used in complex spinal procedures. The system offers two screws designed to address multiple pathologies. The Multi Planar Adjusting (MPA) Screw gives surgeons the flexibility of a variable angle posted screw for targeted, controlled correction maneuvers. [...]

(MDT) Medtronic Launches New Product for Complex Pinal Procedures

Medtronic Inc. (MDT) recently launched a new TSRH 3Dx Spinal System, which is a hook, rod and screw system used in complex spinal procedures. The system offers two screws designed to address multiple pathologies. The Multi Planar Adjusting (MPA) Screw gives surgeons the flexibility of a variable angle posted screw for targeted, controlled correction maneuvers. The OSTEOGRIP Screw enhances bone fixation by incorporating a dual-lead thread pattern that reduces toggle at the bone-screw interface.

The new pedicle screw system has a unique technology that addresses multiple spinal pathologies, from degenerative disc disease to spinal deformity. The product offers an alternative to patients for spinal stabilization with fusion. It works for patients suffering from degenerative spinal conditions, deformity, or injury of the thoracic, lumbar, and sacral spine. The TSRH Spinal System also provides Chromaloy rods and a minimally invasive capability.

We think that the new product will be widely accepted by orthopedic surgeons as a result of its unique features. This will expand Medtronic’s revenues in the Spinal and Biologics segment.
Medtronic is one of the world’s leading medical technology companies, specializing in implantable and interventional therapy devices and products. The company’s main competitors include St. Jude Medical (STJ) and Boston Scientific Corporation (BSX).

Medtronic’s management has a typical “ONE Medtronic" approach that encompasses the following goals: drive sustainable long-term growth of 9%−11% through innovation, focus on operating margins − increase by 300 to 400 basis points, EPS growth of 11%−14% and return a minimum of 40%−50% of free cash flow to shareholders annually, and align the organization for consistent execution. Medtronic’s fiscal first quarter results indicate that the company is well on track to achieve these goals.

Read the full analyst report on "MDT"
Read the full analyst report on "STJ"
Read the full analyst report on "BSX"
Zacks Investment Research

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5122603 for the full story.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5121824 for the full story.

Medtronic (NYSE: MDT) receives an FDA letter after an inspection of one of its facilities.

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

FDA Noted that the Company’s Promised Corrective Actions Appear to be Adequate to Resolve the Issues Raised in the Letter